Tuan Khoi Nguyen

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion4 trích dẫn
International Journal of Cancer · 2025 · DOI

The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases3 trích dẫn
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 trích dẫn
Therapeutic Advances in Medical Oncology · 2024 · DOI

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam3 trích dẫn
BMC Cancer · 2024 · DOI

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 trích dẫn
Therapeutic Advances in Medical Oncology · 2025 · DOI

A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 trích dẫn
Research Square · 2023 · DOI

Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI

Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam
Therapeutic Advances in Respiratory Disease · 2025 · DOI